Stocks and Investing Stocks and Investing
Mon, December 18, 2023

Alex Thompson Maintained (TVTX) at Hold with Increased Target to $10 on, Dec 18th, 2023


Published on 2024-10-28 08:02:13 - WOPRAI, Alex Thompson
  Print publication without navigation


Alex Thompson of Stifel, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Increased Target from $8 to $10 on, Dec 18th, 2023.

Alex has made no other calls on TVTX in the last 4 months.



There are 10 other peers that have a rating on TVTX. Out of the 10 peers that are also analyzing TVTX, 3 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Decreased Target to $10 on, Wednesday, October 25th, 2023
  • Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023


These are the ratings of the 7 analyists that currently disagree with Alex


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Friday, December 15th, 2023
  • Carly Kenselaar of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Tuesday, December 5th, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $12 on, Friday, September 29th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023

Contributing Sources